Likewise, high TSPAN4 expression correlated with worse overall survival in GBM, LGG, GBMLGG, ACC, STAD, LUSC, and BLCA, whereas in MESO, high expression corresponded to improved overall survival compared with low expression (Figure 3B). The gene discussed is TSPAN4; the disease is glioblastoma.